General Information of the Compound
Compound ID |
CP0390023
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(6aR)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,8]naphthyridine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C11H15N3
|
||||||||||||||||||
Molecular Weight |
189.262
|
||||||||||||||||||
Canonical SMILES |
C1CN2[C@H](CCc3cccnc23)CN1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C11H15N3/c1-2-9-3-4-10-8-12-6-7-14(10)11(9)13-5-1/h1-2,5,10,12H,3-4,6-8H2/t10-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
NDVQTLLBHWRZQL-SNVBAGLBSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C